Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | PPM1B | O75688 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3789516 | 0.91 | PPM1B (0.36) | ALDH1A1PPM1BPTPN1PPP1CCL3MBTL1 | |
| SCHEMBL3792975 | 0.88 | PPM1B (0.33) | SMN1; SMN2ALDH1A1KMT2AMEN1PPM1B | |
| SCHEMBL3789382 | 0.87 | ALDH1A1 (0.39) | SMN1; SMN2ALDH1A1KMT2AMEN1RXFP1 | |
| SCHEMBL3785404 | 0.85 | SMN1; SMN2 (0.33) | SMN1; SMN2ALDH1A1KMT2AMEN1RXFP1 | |
| SCHEMBL3289307 | 0.80 | ATM (0.35) | SMN1; SMN2ALDH1A1KMT2AMEN1RXFP1 | |
| SCHEMBL6351424 | 0.79 | ALDH1A1 (0.44) | SMN1; SMN2ALDH1A1KMT2AMEN1RXFP1 | |
| SCHEMBL3794014 | 0.79 | ALDH1A1 (0.34) | ALDH1A1KMT2AMEN1PPM1BPTPN1 | |
| SCHEMBL6359904 | 0.77 | ALDH1A1 (0.46) | SMN1; SMN2ALDH1A1KMT2AMEN1RXFP1 | |
| SCHEMBL3788867 | 0.77 | ALDH1A1 (0.41) | SMN1; SMN2ALDH1A1PPM1BPTPN1PPP1CC | |
| SCHEMBL11797007 | 0.76 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1PPM1BPTPN1PPP1CC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7696366-B2 | Production process of bifunctional epoxy monomer by selective oxidation of diolefin compound | SHOWA DENKO K.K. (JP) | 2010-04-13 | — | — | US | disclosed |
| EP-1891031-B1 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | SHOWA DENKO KK (JP) | 2009-03-11 | — | — | EP | disclosed |
| US-20090030217-A1 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | SHOWA DENKO K.K. (JP) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030217-A1 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | DUOX2, DUOX1, DDT | SMN1; SMN2 2870/4885ALDH1A1 747/4885KMT2A 2075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.